HealthDay (6/5, Dallas) reports researchers found “older women who get mammograms are more likely to also seek screenings for cervical cancer and osteoporosis.” The findings were published in the journal Radiology.
Aunt Minnie (6/5, Yee) and the Radiology Business Journal (6/5, Walter) also cover the story.
The New York Times (6/3, Grady, Subscription Publication) reports that research indicates “many women with early-stage breast cancer who would receive chemotherapy under current standards do not actually need it, according to a major international study that is expected to quickly change medical treatment.” Investigators “found that gene tests on tumor samples were able to identify women who coustyle="color:#0E4DA4"ld safely skip chemotherapy and take only a drug that blocks the hormone estrogen or stops the body from making it.” The findings were published in the New England Journal of Medicine and presented at the American Society of Clinical Oncology meeting.
The Radiology Business Journal (5/31, Walter) reports researchers found that “false-positive breast biopsies cost the US healthcare system approximately $2.18 billion each year.” The findings were published in ClinicoEconomics and Outcomes Research.
HealthDay (5/31, Reinberg) reports researchers found that many breast cancer survivors, “especially black women,” are not receiving the mammograms they need. The findings were published in the Journal of the National Comprehensive Cancer Network.
The Radiology Business Journal (5/25, Walter) reported researchers found that “machine learning techniques perform well when tasked with predicting malignancy in breast lesions identified during breast cone-beam CT (CBCT) exams.” The findings were published in the American Journal of Roentgenology.